Blockade of Orexin-1 Receptors Attenuates Orexin-2 Receptor Antagonism-Induced Sleep Promotion in the Rat-Reference-Cited by-同舟云学术

Blockade of Orexin-1 Receptors Attenuates Orexin-2 Receptor Antagonism-Induced Sleep Promotion in the Rat

Published:2009-04-10 Issue:1 Volume:330 Page:142-151
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Dugovic Christine,Shelton Jonathan E.,Aluisio Leah E.,Fraser Ian C.,Jiang Xiaohui,Sutton Steven W.,Bonaventure Pascal,Yun Sujin,Li Xiaorong,Lord Brian,Dvorak Curt A.,Carruthers Nicholas I.,Lovenberg Timothy W.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference36 articles.

1. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats

2. Pharmacological characterization of JNJ-28583867, a histamine H3 receptor antagonist and serotonin reuptake inhibitor

3. Orexins (hypocretins) directly excite tuberomammillary neurons

4. Selective Blockade of 5-Hydroxytryptamine (5-HT)7Receptors Enhances 5-HT Transmission, Antidepressant-Like Behavior, and Rapid Eye Movement Sleep Suppression Induced by Citalopram in Rodents

5. Hypocretin-1 Modulates Rapid Eye Movement Sleep through Activation of Locus Coeruleus Neurons

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The differential effects of blocking retinal orexin receptors on the expression of retinal c-fos and hypothalamic Vip, PACAP, Bmal1, and c-fos in Male Wistar Rats;Experimental Eye Research;2024-07

2. On the kinetic features of orexin receptor antagonists at orexin receptors, transduction systems and receptor binding;Medicine in Drug Discovery;2024-06

3. Pain-Insomnia-Depression Syndrome: Triangular Relationships, Pathobiological Correlations, Current Treatment Modalities, and Future Direction;Pain and Therapy;2024-05-30

4. Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities;Neuropharmacology;2024-03

5. Danavorexton (TAK-925): an orexin receptor 2 agonist as a new ‘arousal’ agent;British Journal of Anaesthesia;2024-03